日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis

对接受抗纤维化治疗的进行性非特发性肺纤维化患者的治疗效果、耐受性和生存率进行分析

Ocal, Nesrin; Cilli, Aykut; Mogulkoc, Nesrin; Coskun, Funda; Ursavas, Ahmet; Hanta, Ismail; Ozyurek, Berna Akinci; Ensarioglu, Kerem; Ezircan, Alper; Yuksel, Esra; Arikan, Beste; Uzer, Fatih; Ozdemirel, Tugce Sahin; Misirci, Salim; Deniz, Pelin Pinar; Basyigit, Ilknur; Kumbasar, Ozlem Ozdemir

Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat

巴瑞替尼对难治性类风湿关节炎患者是否有效且安全?与非难治性类风湿关节炎组的比较数据

Ekin, Ali; Misirci, Salim; Görünen, Ahmet; Coskun, Belkis Nihan; Yagiz, Burcu; Dalkilic, Ediz; Pehlivan, Yavuz

Efficacy and safety of tofacitinib in rheumatoid arthritis: Nine years of real-world data

托法替尼治疗类风湿性关节炎的疗效和安全性:九年真实世界数据

Ekin, Ali; Misirci, Salim; İldemir, Selin; Coskun, Belkıs Nihan; Yagiz, Burcu; Dalkilic, Ediz; Pehlivan, Yavuz